CALC Acute Pancreatitis Clinical Experts Event

Dr. Leheny has over 30 years of experience in the life sciences industry as a scientist, a research analyst at several investment banks and as a venture capital investor. Dr. Leheny is a Founding Managing Director for Valence Advantage Life Sciences, a venture firm based in New York. Prior to Valence, she co-founded Caxton Advantage Venture Partners, from which Valence Life Sciences emerged. Before that, she was a Senior Vice President and Head of the biotechnology research team at Lehman Brothers. She also led the biotechnology research team at UBS Warburg. She started her biotechnology research career at Hambrecht and Quist. Dr. Leheny obtained an A.B. in Chemistry with honors from Harvard College, and a Ph.D. in Chemistry from Columbia University. She did post-doctoral work at the University of California, Berkeley, where she was an NIH fellow and a lecturer.

Dr. Miller is Clinical Associate Professor of Emergency Medicine at Henry Ford Health and Michigan State University. Dr. Miller also serves as Associate Director of Emergency Care Research at Henry Ford Health. He has over 12 years of experience in emergency care and critical care clinical trials. Dr. Miller received a M.D. from the Indiana University School of Medicine as well as a M.S. from the University of Michigan School of Public Health.

Dr. Papachristou is a professor of Medicine, the Floyd Beman Endowed Chair in Gastroenterology and the division director for Gastroenterology, Hepatology and Nutrition at The Ohio State University College of Medicine. He is a nationally recognized expert therapeutic endoscopist, specializes in pancreaticobiliary diseases, and practices state-of-the-art endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS). As a researcher, Dr. Papachristou is in charge of a number of institutional studies and multicenter collaborations. He directs a translational research laboratory focusing on the immunology and therapy of acute pancreatitis and receives research funding from the National Institutes of Health, the U.S. Department of Defense and industry. He has authored over 200 peer-reviewed articles and book chapters. Board certified in gastroenterology, Dr. Papachristou received his medical degree from the University of Patras School of Medicine in Greece, graduating first in his class (summa cum laude). He completed training in Gastroenterology at University of Pittsburgh and Therapeutic Endoscopy at Mayo Clinic in Rochester, Minnesota.

Bio: Dr. Hebbar has over 15 years of clinical development and product development experience in the pharmaceutical and diagnostics industries. Before joining CalciMedica, Dr. Hebbar was a consultant for Mallinckrodt Pharmaceuticals, where he served as the clinical development lead for a global multicenter Phase IV trial. Prior to that, he was the Vice President of Nephrology at Thrasos Innovation where he helped implement a global multicenter Phase II trial of a novel therapeutic compound for acute kidney injury. Before working at Thrasos, Dr. Hebbar served as Medical Vice President and a member of the U.S. Board of Directors at Oncimmune, a company that pioneered the development of autoantibody assay technologies for the early detection of lung cancer. Before joining Oncimmune, Dr. Hebbar served as a Medical Director at Reata Pharmaceuticals, where he was a medical monitor for both a Phase III global multicenter trial and multiple Phase I trials, and the clinical development lead for multiple Phase II trials. Dr. Hebbar began his industry career at Abbott, where he initially served as a Senior Medical Director in the Quality and Regulatory division before transferring to the Diagnostics division, where he supervised a team that provided medical input into product development, supported commercial launches of diagnostic products and led the clinical development of novel biomarkers. Prior to joining Abbott, Dr. Hebbar was a Medical Director at Dialysis Clinics Incorporated and a partner at Kidney Associates of Kansas City where for 12 years he practiced nephrology, hypertension, transplant medicine and critical care medicine. Dr. Hebbar received a B.A. in Natural Sciences from The Johns Hopkins University and a M.D. from Tulane University School of Medicine. He completed a residency in Internal Medicine and a fellowship in Critical Care Medicine, both at Hennepin County Medical Center, a fellowship in Nephrology at the University of Chicago and a fellowship in Clinical Medical Ethics at The Maclean Center for Clinical Medical Ethics at the University of Chicago.